Form 4: Gevo General Counsel Receives Equity Compensation
Statement of Changes in Beneficial Ownership
Gevo, Inc. General Counsel David Michael Kettner was granted 133,232 shares of restricted stock and 153,937 stock options.
Summary
- General Counsel David Michael Kettner received an equity grant on May 20, 2026.
- The grant includes 133,232 shares of restricted common stock.
- The grant includes 153,937 stock options with an exercise price of $1.64 per share.
- Both the restricted stock and the stock options vest in three equal annual installments starting on the first anniversary of the grant date.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation, which is neutral in terms of immediate market impact.
Positives
- Alignment of executive interests with long-term shareholder value through equity-based compensation.
- Retention of key legal leadership through multi-year vesting schedules.
Negatives
- Potential for future shareholder dilution upon the exercise of stock options and vesting of restricted stock.
Risks
- Continued service requirement for vesting creates dependency on executive retention.
- Market price volatility may impact the ultimate value of the equity compensation.
Future Outlook
The equity grants are subject to a three-year vesting schedule, contingent upon the reporting person's continued service with the issuer.
Industry Context
StockSavvy.ai notes that equity-based compensation for executive officers is a standard practice in the biotechnology and renewable energy sectors to incentivize long-term performance and retain talent.
Comparison to Industry Standards
- The use of restricted stock and options with multi-year vesting is consistent with standard corporate governance practices for U.S. publicly traded companies.
- The grant size is commensurate with typical compensation packages for General Counsel roles in mid-cap growth companies.
Stakeholder Impact
- Shareholders may experience minor dilution upon the eventual exercise or vesting of these equity instruments.
Next Steps
- Vesting of the first installment of restricted stock and options on May 20, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/20/2026 | Date of the equity grant transaction. |
| 05/22/2026 | Date the Form 4 was filed with the SEC. |
| 05/19/2036 | Expiration date of the granted stock options. |
Keywords
Gevo, GEVO, Form 4, Insider Trading, Equity Compensation, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.